Advertisement

Neuropsychological Effects of Stimulant Medication on Children’s Learning and Behavior

  • Ronald T. Brown
  • Brian P. Daly

Stimulants are psychotropic drugs that produce excitation of the central nervous system (CNS). Stimulants have been used in the management of children and adolescents since the 1930s when Dr Charles Bradley first used Benzedrine to treat children with behavioral disturbances (Bradley, 1937).

Keywords

Academic Achievement Disruptive Behavior ADHD Symptom Tourette Syndrome Conduct Disorder 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Abikoff, H., Hechtman, L., Klein, R. G., Gallagher, R., Fleiss, K., Etcovitch, J., et al. (2004). Social functioning in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. Journal of the American Academy of Child & Adolescent Psychiatry, 43, 820-829.Google Scholar
  2. Adesman, A. R. (2002). New medications for treatment of children with Attention-Deficit/Hyperactivity Disorder: Review and commentary. Pediatric Annals, 31, 514-523.PubMedGoogle Scholar
  3. Alto, J. L., & Frankenberger, W. (1994). Effects of methylphenidate on academic achievement from first to second grade. International Journal of Disability, Development and Education, 42, 259-273.Google Scholar
  4. Aman, M. G., Buican, B., & Arnold, L. E. (2003). Methylphenidate treatment in children with borderline IQ and mental retardation: Analysis of three aggregated studies. Journal of Child and Adolescent Psychopharmacology, 13, 29-40.PubMedGoogle Scholar
  5. Aman, M. G., Kern, R. A., McGhee, D. E., & Arnold, L. E. (1993). Fenfluramine and methylphenidate in children with mental retardation and Attention Deficit Hyperactivity Disorder: Laboratory effects. Journal of Autism & Developmental Disorder, 23, 491-506.Google Scholar
  6. Aman, M. G., Kern, R. A., Osborne, P., Tumuluru, R., Rojahn, J., & Del Medico, V. (1997). Fenfluramine and methylphenidate in children with mental retardation and borderline IQ: Clinical effects. American Journal of Mental Retardation, 101, 521-534.PubMedGoogle Scholar
  7. Aman, M. G., Marks, R. E., Turbott, S. H., Wilsher, C. P., & Merry, S. N. (1991). Clinical effects of methylphenidate and thioridazine in intellectually subaverage children. Journal of the American Academy of Child & Adolescent Psychiatry, 30, 246-256.Google Scholar
  8. Aman, M., & Werry, J. S. (1982). Methylphenidate and diazepam in severe reading retardation. Journal of the American Academy of Child Psychiatry, 2, 31-37.Google Scholar
  9. American Academy of Child & Adolescent Psychiatry. (2002). Practice parameters for the use of stimulant medication. Journal of the American Academy of Child & Adolescent Psychiatry, 41, 1146-1147.Google Scholar
  10. American Psychiatric Association. (1980). Diagnostic and Statistical Manual of Mental Disorders (3rd ed.). Washington, DC: Author.Google Scholar
  11. American Psychiatric Association. (1987). Diagnostic and statistical manual for mental disorders (3rd rev. ed.). Washington, DC: Author.Google Scholar
  12. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.Google Scholar
  13. American Psychiatric Association. (2000). Diagnostic and statistical manual for mental disorders (4th ed., text revision). Washington, DC: Author.Google Scholar
  14. Amery, B., Minichiello, M. D., & Brown, G. L. (1984). Aggression in hyperactive boys: response to D-amphetamine. Journal of the American Academy of Child & Adolescent Psychiatry, 23, 291-294.Google Scholar
  15. Anderson, V., & Taylor, H. G. (1999). Meningitis in childhood: Neuropsychological complications. In K. O. Yeates, M. D. Ris, & H. G. Taylor (Eds.), Pediatric neuropsychology: Research, theory and practice (pp. 117-148). New York: Guilford Press.Google Scholar
  16. Angold, A., & Costello, E. J. (1997). Stimulant medication: A general population perspective [Abstract]. New Clinical Drug Evaluation Unit (NCDEU) Abstracts of the 37th Annual Meeting, May 27-30.Google Scholar
  17. Angold, A., Erkanli, A., Egger, H. L., & Costello, E. J. (2000). Stimulant treatment for children: A community perspective. Journal of the American Academy of Child & Adolescent Psychiatry, 39, 975-984.Google Scholar
  18. Arcia, E., Fernandez, M. C., & Jaquez, M. (2004). Latina mothers’stances on stimulant medication: Complexity, conflict, and compromise. Journal of Developmental & Behavioral Pediatrics, 25, 311-317.Google Scholar
  19. Arnold, L. (2000). Methylphenidate vs. amphetamine: Comparative review. Journal of Attention Disorders, 3, 200-211.Google Scholar
  20. Atkins, M. S., & Pelham, W. E. (1991). School-based assessment of Attention Deficit Hyperactivity Disorder. Journal of Learning Disabilities, 24, 197-204.PubMedGoogle Scholar
  21. Ballinger, C. T., Varley, C. K., & Nolen, P. A. (1984). Effects of methylphenidate on reading in children with ADD. American Journal of Psychiatry, 141, 1590-1593.PubMedGoogle Scholar
  22. Barkley, R. A. (1990). Attention deficit Hyperactivity Disorder: A handbook for diagnosis and treatment. New York: Guilford Press.Google Scholar
  23. Barkley, R. A. (1995). Taking charge of ADHD: The complete, authoritative guide for parents. New York: Guilford Press.Google Scholar
  24. Barkley, R. A. (1997). ADHD and the nature of self-control. New York: Guilford Press.Google Scholar
  25. Barkley, R. A. (2005). Taking charge of ADHD: The complete, authoritative guide for parents (3rd ed.). New York: Guilford Press.Google Scholar
  26. Barkley, R. A., & Cunningham, C. E. (1978). Do stimulant drugs improve academic performance of hyperkinetic children? Clinical Pediatrics, 17, 85-92.PubMedGoogle Scholar
  27. Barkley, R. A., DuPaul, G. J., & Costello, A. (1993). Stimulants. In J. S. Werry, & M. G. Aman (Eds.), Practitioners guide to psychoactive drugs for children and adolescents (pp. 205-237). New York: Plenum.Google Scholar
  28. Barkley, R. A., DuPaul, G. J., & McMurray, M. B. (1991). Attention Deficit Disorder with and without hyperactivity: Clinical response to three dose levels of methylphenidate. Pediatrics, 87, 519-531.PubMedGoogle Scholar
  29. Barkley, R. A., Fischer, M., Smallish, L., & Fletcher, K. (2003). Does the treatment of Attention-Deficit/Hyperactivity Disorder with stimulants contribute to drug use/abuse? A 13-year prospective study. Pediatrics, 111, 97-109.PubMedGoogle Scholar
  30. Barkley, R. A., Fischer, M., Smallish, L., & Fletcher, K. (2004). Young adult follow-up of hyperactive children: Antisocial activities and drug use. Journal of Child Psychology & Psychiatry, 45, 195-211.Google Scholar
  31. Barkley, R. A., McMurray, M. B., Edelbrock, C. S., & Robbins, K. (1989). The response of aggressive and nonaggressive ADHD children to two doses of methylphenidate. Journal of the American Academy of Child & Adolescent Psychiatry, 28, 873-881.Google Scholar
  32. Barkley, R. A., McMurray, M. B., Edelbrock, C. S., & Robbins, K. (1990). Side effects of methylphenidate in children with Attention Deficit Hyperactivity Disorder: A systematic, placebo-controlled evaluation. Pediatrics, 86, 184-192.PubMedGoogle Scholar
  33. Barnett, R., Maruff, P., Vance, A., Luk, E. S. L., Costin, J., Wood, C., et al. (2001). Abnormal executive function in Attention Deficit Hyperactivity Disorder: The effect of stimulant medication and age on spatial working memory. Psychological Medicine, 31, 1107-1115.PubMedGoogle Scholar
  34. Bedard, A. C., Martinussen, R., Ickowicz, A., & Tannock, R. (2004). Methylphenidate improves visual-spatial memory in children with Attention-Deficit/Hyperactivity Disorder. Child & Adolescent Social Work Journal, 21, 260-268.Google Scholar
  35. Benedetto-Nasho, E., & Tannock, R. (1999). Math computation performance and error patterns of children with Attention Deficit Hyperactivity Disorder. Journal of Attention Disorders, 3, 121-134.Google Scholar
  36. Ben Pazi, H., Gross-Tsur, V., Bergman, H., & Shalev, R. S. (2003). Abnormal rhythmic motor response in children with attention-deficit-hyperactivity disorder. Developmental Medicine & Child Neurology, 45, 743-745.Google Scholar
  37. Bennett, F. C., Brown, R. T., Craver, J., & Anderson, D. (1999). Stimulant medication for the child with attention-deficit/hyperactivity disorder. Pediatric Clinics of North America, 46, 929-943.PubMedGoogle Scholar
  38. Biederman, J., Faraone, S. V., & Lahey, K. (1992). Comorbidity of diagnosis in attention-deficit hyperactivity disorder. Child & Adolescent Psychiatric Clinics of North America, 1, 335-360.Google Scholar
  39. Biederman, J., Newcorn, J., & Sprich, S. (1991). Comorbidity of Attention Deficit Hyperactivity Disorder with conduct, depressive, anxiety, and other disorders. American Journal of Psychiatry, 148, 564-577.PubMedGoogle Scholar
  40. Biederman, J., Wilens, T., Mick, E., Spencer, T., & Faraone, S. V. (1999). Pharmacotherapy of Attention-Deficit/Hyperactivity Disorder reduces risk for substance use disorder. Pediatrics, 104, E20.PubMedGoogle Scholar
  41. Blackman, J. A. (1999). Attention-Deficit/Hyperactivity Disorder in preschoolers: Does it exist and should we treat it? Pediatric Clinics of North America, 46, 1011-1025.PubMedGoogle Scholar
  42. Blum, N. J., Mauk, J. E., McComas, J. J., & Mace, F. C. (1996). Separate and combined effects of methylphenidate and a behavioral intervention on disruptive behavior in children with mental retardation. Journal of Applied Behavior Analysis, 29, 305-319.PubMedGoogle Scholar
  43. Bradley, C. (1937). The behaviour of children receiving benzedrine. American Journal of Psychiatry, 94, 577-585.Google Scholar
  44. Brown, R. T., & Borden, K. A. (1989). Neuropsychological effects of stimulant medication on children’s learning and behavior. In C. R. Reynolds, & E. Fletcher-Janzen (Eds.), Handbook of clinical child neuropsychology (pp. 443-474). New York: Plenum Press.Google Scholar
  45. Brown, R. T., & La Rosa, A. (2002). Recent developments in the pharmacotherapy of attention-deficit/hyperactivity disorder. Professional Psychology: Research and Practice, 33, 591-595.Google Scholar
  46. Brown, R. T., & Sammons, M. T. (2003). Pediatric psychopharmacology: A review of new developments and recent research. Professional Psychology: Research & Practice, 33, 135-147.Google Scholar
  47. Brown, R. T., & Sawyer, M. G. (1998). Medications for school-age children: Effects on learning and behavior. New York: Guilford Press.Google Scholar
  48. Brown, R. T., & Sleator, E. K. (1979). Methylphenidate in hyperkinetic children: Differences in dose effects on impulsive behavior. Pediatrics, 64, 408-411.PubMedGoogle Scholar
  49. Brown, R. T., Dingle, A. D., & Dreelin, E. (1997). Neuropsychological effects of stimulant medication on children’s learning and behavior. In C. R. Reynolds, & E. Fletcher-Janzen (Eds.), Handbook of clinical child neuropsychology (pp. 539-572). New York: Plenum Press.Google Scholar
  50. Brown, R. T., Dingle, A., & Landau, S. (1994). Overview of psychopharmacology in children and adolescents. School Psychology Review, 9, 4-25.Google Scholar
  51. Bowen, J., Fenton, T., & Rappaport, L. (1991). Stimulant medication and Attention-Deficit Hyperactivity Disorder: The child’s perspective. American Journal of Diseases of Children, 145, 291-295.PubMedGoogle Scholar
  52. Brown, R. T., Mulhern, R., & Simonian, S. (2002). Diseases of the blood and blood forming organs. In T. Boll (Ed.), S. Bennett-Johnson, N. Perry, & R. Rozensky (Vol. 1 Eds.), Handbook of clinical health psychology: Volume 1. Medical disorders and behavioral applications (Vol. 3, pp. 101-141). Washington, DC: American Psychological Association.Google Scholar
  53. Brown, R. T., Amler, R. W., Freeman, W. S., Perrin, J. M., Stein, M. T., Feldman, H. M., et al. (2005). Treatment of attention-deficit/hyperactivity disorder: Overview of the evidence. Pediatrics, 115, 749-757.Google Scholar
  54. Broyd, S. J., Johnstone, S. J., Barry, R. J., Clarke, A. R., McCarthy, R., Selikowitz M., et al. (2005). The effect of methylphenidate on response inhibition and the event-related potential of children with Attention Deficit/Hyperactivity Disorder. International Journal of Psychophysiology, 58, 47-58.PubMedGoogle Scholar
  55. Buhrmester, D., Camparo, L., Christensen, A., Gonzalez, L., & Hinshaw, S. (1992). Mothers and fathers interacting in dyads and triads of normal and hyperactive sons. Developmental Psychology, 28, 500-509.Google Scholar
  56. Bukstein, O. G., & Kolko, D. J. (1998). Effects of methylphenidate on aggressive urban children with Attention Deficit Hyperactivity Disorder. Journal of Clinical & Child Psychology, 27, 340-351.Google Scholar
  57. Burd, L. (1995). Children with Tourette Syndrome: A handbook for parents and teachers. Grand Forks, ND: Jessica Kingsley.Google Scholar
  58. Butler, R. W., & Mulhern, R. K. (2005). Neurocognitive interventions for children and adolescents surviving cancer. Journal of Pediatric Psychology, 30, 65-78.PubMedGoogle Scholar
  59. Butte, N., Treuth, M., Voigt, R., Llorente, A., & Heird, W. (1999). Stimulant medications decrease energy expenditure and physical activity in children with Attention Deficit/Hyperactivity Disorder. Journal of Pediatrics, 135, 203-207.PubMedGoogle Scholar
  60. Calello, D., & Osterhoudt, K. (2004). Acute psychosis associated with therapeutic use of dextroamphetamine. Pediatrics, 113, 1466.PubMedGoogle Scholar
  61. Canadian Pharmacists Association. (1999). Ritalin product monograph. In M. C. Gillis (Ed.), CPS Compendium of pharmaceuticals and specialties (34th ed.) (pp. 1573-1574). Ottawa: Author.Google Scholar
  62. Carlson, C. L., Pelham, W. E., Milich, R., & Dixon, M. J. (1992). Single and combined effects of methylphenidate and behavior therapy on the classroom behavior, academic performance and self-evaluations of children with Attention Deficit-Hyperactivity Disorder. Journal of Abnormal Child Psychology, 20, 213-232.PubMedGoogle Scholar
  63. Carlson, G. A., & Kelly, K. L. (2003). Stimulant rebound: How common is it and what does it mean? Journal of Child & Adolescent Psychopharmacology, 13, 137-142.Google Scholar
  64. Casat, C. D., Gualtieri, C. T., Weller, E., Reader, M., Reiss, A., Weller, R. A., et al. (1996). Bupropion hydrochloride in Attention Deficit Disorder with hyperactivity. Journal of the American Academy of Child & Adolescent Psychiatry, 35, 1314-1321.Google Scholar
  65. Casey, B. J., Castellanos, F. X., Giedd, J. N., Marsh, W. L., Hamburger, S. D., Schubert, A. B., et al. (1997). Implication of right frontostriatal circuitry in response inhibition and Attention-Deficit/Hyperactivity Disorder. Journal of the American Academy of Child & Adolescent Psychiatry, 36, 374-383.Google Scholar
  66. Castellanos, F. X., Giedd, J. N., Elia, J., Marsh, W. L., Ritchie, G. F., Hamburger, S. D., et al. (1997). Controlled stimulant treatment of ADHD and comorbid Tourette’s Syndrome: Effects of stimulant and dose. Journal of the American Academy of Child & Adolescent Psychiatry, 36, 589-596.Google Scholar
  67. Castellanos, F. X. (2002). Anatomic magnetic resonance imaging studies of Attention-Deficit/Hyperactivity Disorder. Dialogues in Clinical Neuroscience, 4, 444-448.Google Scholar
  68. Castellanos, F. X., & Acosta, M. T. (2004). The neuroanatomy of Attention Deficit/Hyperactivity Disorder. Review of Neurology, 38, S131-S136.Google Scholar
  69. Castellanos, F. X., Lee, P. P., Sharp, W., Jeffries, N. O., Greenstein, D. K., Clasen, L. S., et al. (2002). Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder. Journal of the American Medical Association, 288, 1740-1748.PubMedGoogle Scholar
  70. Castellanos, F. X., Sharp, W. S., Gottesman, R. F., Greenstein, D. K., Giedd, J. N., & Rapoport, J. L. (2003). Anatomic brain abnormalities in monozygotic twins discordant for Attention Deficit Hyperactivity Disorder. American Journal of Psychiatry, 160, 1693-1696.PubMedGoogle Scholar
  71. Chabot, R. J., Orgill, A. A., Crawford, G., Harris, M. J., & Serfontein, G. (1999). Behavioral and electrophysiologic predictors of treatment response to stimulants in children with attention disorders. Journal of Child Neurology, 14, 343-351.PubMedGoogle Scholar
  72. Chacko, A., Pelham,W. E., Gnagy, E. M., Greiner, A., Vallano, G., Bukstein, O., et al. (2005). Stimulant medication effects in a summer treatment program among young children with Attention-Deficit/Hyperactivity Disorder. Journal of the American Academy of Child & Adolescent Psychiatry, 44, 249-257.Google Scholar
  73. Charach, A., Ickowicz, A., & Schachar, R. (2004). Stimulant treatment over five years: Adherence, effectiveness, and adverse effects. Journal of the American Academy of Child & Adolescent Psychiatry, 43, 559-567.Google Scholar
  74. Cherland, E., & Fitzpatrick, R. (1999). Psychotic side effects of psychostimulants: A 5-year review. Canadian Journal of Psychiatry, 44, 811-813.Google Scholar
  75. Clarke, A. R., Barry, R. J., McCarthy, R., & Selikowitz, M. (1998). EEG analysis in attention-deficit/hyperactivity disorder: a comparative study of two subtypes. Psychiatry Research, 81, 19-29.PubMedGoogle Scholar
  76. Clarke, A. R., Barry, R. J., McCarthy, R., & Selikowitz, M. (2002). EEG differences between good and poor responders to MPH and dexamphetamine in children with attention-deficit/hyperactivity disorder. Clinical Neurophysiology, 113, 194-205.PubMedGoogle Scholar
  77. Claude-Bedard, A., Ickowicz, I., Logan, G. D., Hogg-Johnson, S., Schachar, R., & Tannock, R. (2003). Selective inhibition in children with attention-deficit hyperactivity disorder off and on stimulant medication. Journal of Abnormal Child Psychology, 31, 315-327.Google Scholar
  78. Coie, J. K., & Dodge, K. A. (1998). Aggression and antisocial behavior. In E. M. Hetherington (Ed.), & W. Damon (Series Ed.), Handbook of child psychology: Vol. 3: Social, emotional, and personality development (pp. 779-862). New York: Wiley.Google Scholar
  79. Connor, D. F. (2002). Preschool Attention Deficit Hyperactivity Disorder: A review of prevalence, diagnosis, neurobiology, and stimulant treatment. Journal of Developmental & Behavioral Pediatrics, 23, S1-S9.Google Scholar
  80. Conners, C. K., Eisenberg, L., & Barcai, A. (1967). Effect of dextroamphetamine on children: Studies on subjects with learning disabilities and school behavior problems. Archives of General Psychiatry, 17, 478-485.Google Scholar
  81. Connor, D. F., Glatt, S. J., Lopez, I. D., Jackson, D., & Melloni, R. H., Jr. (2002). Psychopharmacology and aggression. I: A meta-analysis of stimulant effects on overt/covert aggression-related behaviors in ADHD.Journal of the American Academy of Child & Adolescent Psychiatry, 41, 253-261.Google Scholar
  82. Conners, C. K. (1997). Conners’ Rating Scales—Revised [technical manual]. Toronto: Multi-Health Systems.Google Scholar
  83. Conners, C. K., Epstein, J. N., March, J. S., Angold, A., Wells, K. C., Klaric, J., et al. (2001). Multimodal treatment of ADHD in the MTA: An alternative outcome analysis. Journal of the American Academy of Child & Adolescent Psychiatry, 40, 159-167.Google Scholar
  84. Cooter, R. B., Jr. (1988). Effects of Ritalin on reading. Academic Therapy, 23, 461-469.Google Scholar
  85. Coyle, J. T. (2000). Psychotropic drug use in very young children. Journal of the American Medical Association, 283, 1059-1060.PubMedGoogle Scholar
  86. Cuffe, S. P., McKeown, R. E., Jackson, K. L., Addy, C. L., Abramson, R., & Garrison, C. Z. (2001). Prevalence of Attention-Deficit/Hyperactivity Disorder in a community sample of older adolescents. Journal of the American Academy of Child & Adolescent Psychiatry, 40, 1037-1044.Google Scholar
  87. Cunningham, C. E., & Siegel, L. S. (1987). The peer interactions of normal and attention deficit disordered boys during free play, cooperative task, and simulated classroom situations. Journal of Abnormal Child Psychology, 15, 247-268.PubMedGoogle Scholar
  88. DeLong, R., Friedman, H., Friedman, N., Gustafson, K., & Oakes, J. (1992). Methylphenidate in neuropsychological sequelae of radiotherapy and chemotherapy of childhood brain tumors and leukemia. Journal of Child Neurology, 7, 462-463.PubMedGoogle Scholar
  89. Denney, C., & Rapport, M. (2001). The cognitive pharmacology of stimulants in children with ADHD. In M. V. Solanto, A. F. T. Arnsten, & F. X. Castellanos (Eds.), Stimulant Drugs and ADHD: Basic and Clinical Neuroscience (pp. 283-302). New York: Oxford University Press.Google Scholar
  90. De Quiros, G. B, Kinsbourne, M., Palmer, R. L., & Tocci Rufo, D. (1994). Attention Deficit Disorder in children: Three clinical variants. Journal of Developmental & Behavioral Pediatrics, 15, 311-319.Google Scholar
  91. De Sonneville, L. M., Nijiokiktjien, C., & Bos, H. (1994). Methylphenidate and information processing. Part 1: Differentiation between responders and non responders; Part 2: Efficacy in responders. Journal of Clinical & Experimental Neuropsychology, 16, 877-897.Google Scholar
  92. Di Michele, F., Prichep, L., John, E. R., & Chabot, R. J. (2005). The neurophysiology of Attention-Deficit/Hyperactivity Disorder. International Journal of Psychophysiology, 58, 81-93.PubMedGoogle Scholar
  93. Disney, E. R., Elkins, I. J., McGue, M., & Iacono, W. G. (1999). Effects of ADHD, conduct disorder, and gender on substance use and abuse in adolescence. American Journal of Psychiatry, 156, 1515-1521.PubMedGoogle Scholar
  94. Doherty, S., Frankenberger, W., Fuhrer, R., & Snider, V. (2000). Children’s self-reported effects of stimulant medication. International Journal of Disability Development & Education, 47, 39-54.Google Scholar
  95. Dos Reis, S., Zito, J. M., Safer, D. J., Soeken, K. L., Mitchell, J. W., & Ellwood, L. (2003). Parental perceptions and satisfaction with stimulant medication for ADHD. Journal of Developmental & Behavioral Pediatrics, 24, 155-162.Google Scholar
  96. Douglas, V. I. (1999). Cognitive control processes in Attention-Deficit/Hyperactivity Disorder. In H. C. Quay, & A. E. Hogan (Eds.), Handbook of disruptive behavior disorders (pp. 105-138). New York: Kluwer Academic/Plenum.Google Scholar
  97. Douglas, V. I., & Peters, K. G. (1979). Toward a clearer definition of the attention deficit of hyperactive children. In E. A. Hale, & M. Lewis (Eds.), Attention and the development of cognitive skills (pp. 173-247). New York: Plenum.Google Scholar
  98. DuPaul, G., & Rapport, M. D. (1993). Does methylphenidate normalize the classroom performance of children with Attention Deficit Disorder? Journal of the American Academy of Child & Adolescent Psychiatry, 32, 190-198.Google Scholar
  99. DuPaul, G. J., & Stoner, G. (1999). Assessing ADHD in the schools [videotape]. New York: Guilford Press.Google Scholar
  100. Douglas, V. I., Barr, R. G., Desilets, J., & Sherman, E. (1995). Do high doses of methylphenidate impair flexible thinking in Attention-Deficit Hyperactivity Disorder? Journal of the American Academy of Child & Adolescent Psychiatry, 34, 877-885.Google Scholar
  101. DuPaul, G. J., Barkley, R. A., & McMurray, M. B. (1991). Therapeutic effects of medication on ADHD: Implications for school psychologists. School Psychology Review, 20, 203-219.Google Scholar
  102. Efron, D., Jarman, F. C., & Barker, M. J. (1997). Methylphenidate versus dexamphetamine in children with Attention Deficit Hyperactivity Disorder: A double-blind crossover trial. Pediatrics, 100, E6.PubMedGoogle Scholar
  103. Efron, D., Jarman, F. C., & Barker, M. J. (1998). Child and parent perceptions of stimulant medication treatment in Attention Deficit Hyperactivity Disorder. Journal of Pediatrics & Child Health, 34, 288-292.Google Scholar
  104. Eisenberg, L., Lachman, R., Molling, P., Lockner, A., Mizelle, J., & Conners, C. (1961). A psychopharmacologic experiment in a training school for delinquent boys: methods, problems and findings. American Journal of Orthopsychiatry, 33, 431-447.Google Scholar
  105. Elia, J., Borcherding, B., Rapoport, J., & Keysor, C. (1991). Methylphenidate and dextroamphetamine treatments of hyperactivity: Are there true non-responders? Psychiatry Research, 36, 141-155.PubMedGoogle Scholar
  106. Elia, J., Welsh, P. A., Gullota, C. S., & Rapoport, J. L. (1993). Classroom academic performance: Improvement with both methylphenidate and dextroamphetamine in ADHD boys. Journal of Child Psychology & Psychiatry, 34, 785-804.Google Scholar
  107. Elliott, S. N. (1988). Acceptability of behavioral treatments in educational settings. In J. C. Witt, S. W. Elliott, & F. M. Gresham (Eds.), Handbook of behavior therapy in education (pp. 121-150). New York: Plenum Press.Google Scholar
  108. Ernst, M., Liebenauer, L. L., Tebeka, D., Jons, P. H., Eisenhofer, G., Murphy, D. L., et al. (1997). Selegiline in ADHD adults: plasma monoamines and monoamine metabolites. Neuropsychopharmacology, 16, 276-284.PubMedGoogle Scholar
  109. Ernst, M., Zametkin, A. J., Matochik, J. A., Pascualvaca, D., Jons, P. H., & Cohen, R. M. (1999). High midbrain [18F] DOPA accumulation in children with Attention Deficit Hyperactivity Disorder. American Journal of Psychiatry, 156, 1209-1215.PubMedGoogle Scholar
  110. Evans, S. W., Pelham, W. E., Smith, B. H. Bukstein, O., Gnagy, E. M., Greiner, A. R., et al. (2001). Dose-response effects of methylphenidate on ecologically valid measures of academic performance and classroom behavior in adolescents with ADHD. Experimental and Clinical Psychopharmacology, 9, 163-175.Google Scholar
  111. Farley, S. E., Adams, J. S., Lutton, M. E., & Scoville, C. (2005). Clinical Inquiries: What are effective treatments for oppositional and defiant behaviors in preadolescents? Journal of Family Practice, 54, 164-165.Google Scholar
  112. Faraone, S. V., Biederman, J., Spencer, T., Michelson, D., Adler, L., Reimherr, F., et al., (2005). Efficacy of atomoxetine in adult Attention-Deficit/Hyperactivity Disorder: A drug-placebo response curve analysis. Behavioral & Brain Functions, 1, 16.Google Scholar
  113. Feldman, H., Crumrine, P., Handen, B. L., Alvin, R., & Teodori, J. (1989). Methylphenidate in children with seizures and Attention-Deficit Disorder. American Journal of Diseases of Children, 143, 1081-1086.PubMedGoogle Scholar
  114. Filho, C., Gomes, A., Bodanese, R., Silva, T., Laufer, T., Alvares, J. P., et al. (2005). Comparison of risperidone and methylphenidate for reducing ADHD symptoms in children and adolescents with moderate mental retardation. Journal of the American Academy of Child & Adolescent Psychiatry, 44, 748-755.Google Scholar
  115. Finck, S., Metz-Lutz, M. N., Becache, E., Danion, A., Vuillemin, M. O., & Marescaux, C. (1995). Attention Deficit Hyperactivity Disorder in epileptic children: A new indication for methylphenidate? Annals of Neurology, 38, 520.Google Scholar
  116. Firestone, P., Musten, L. M., Pisterman, S., Mercer, J., & Bennett, S. (1998). Short-term side effects of stimulant medication are increased in preschool children with Attention-Deficit/Hyperactivity Disorder: a double-blind placebo-controlled study. Journal of Child & Adolescent Psychopharmacology, 8, 13-25.Google Scholar
  117. Fitzpatrick, P. A., Klorman, R., Brumaghim, J. T., & Borgstedt, A. D. (1992). Effects of sustained-release and standard preparations of methylphenidate on Attention Deficit Disorder. Journal of the American Academy of Child & Adolescent Psychiatry, 31, 226-234.Google Scholar
  118. Fox, M., Foster, C., & Zito, J. (2000). Building pharmacoepidemiological capacity to monitor psychotropic drug use among children enrolled in Medicaid. American Journal of Medical Quality, 15, 126-136.PubMedGoogle Scholar
  119. Frankenberger, W., & Cannon, C. (1999). Effects of Ritalin on academic achievement from first to fifth grade. International Journal of Disability, Development & Education, 46, 199-221.Google Scholar
  120. Frankenberger, W., Farmer, C., Parker, L., & Cermak, J. (2001). The use of stimulant medication for treatment of Attention-Deficit/Hyperactivity Disorder: A survey of school psychologists’ knowledge, attitudes, and experience. Developmental Disabilities Bulletin, 29, 132-151.Google Scholar
  121. Frankenberger, W., Lozar, B., & Dallas, P. (1990). The use of medication to treat Attention Deficit Hyperactive Disorder (ADHD) in elementary school children. Developmental Disabilities Bulletin, 18, 1-13.Google Scholar
  122. Frierson, R. L., Wey, J., & Tabler, J. B. (1991). Psychostimulants for depression in the medically ill. American Family Physician, 43, 163-170.PubMedGoogle Scholar
  123. Gadow, K. D. (1985). Prevalence and efficacy of stimulant drug use with mentally retarded children and youth. Psychopharmacology Bulletin, 21, 291-303.PubMedGoogle Scholar
  124. Gadow, K. D. (1992). Pediatric psychopharmacology: A review of recent research. Journal of Child Psychology & Psychiatry, 33, 153-195.Google Scholar
  125. Gadow, K. D., Nolan, E., Sprafkin, J., & Sverd, J. (1995). School observations of children with Attention-Deficit Hyperactivity Disorder and comorbid tic disorder: Effects of methylphenidate treatment. Journal of Developmental & Behavioral Pediatrics, 16, 167-176.Google Scholar
  126. Gadow, K. D., Sverd, J., Sprafkin, J., Nolan, E. E., & Ezor, S. N. (1995). Efficacy of methylphenidate for Attention-Deficit Hyperactivity Disorder in children with tic disorder. Archives of General Psychiatry, 52, 444-455.PubMedGoogle Scholar
  127. Gadow, K. D., Sverd, S., Sprafkin, J., Nolan, E. E., & Grossman, S. (1999). Long-term methylphenidate therapy in children with comorbid Attention-Deficit Hyperactivity Disorder and chronic multiple tic disorder. Archives of General Psychiatry, 56, 330-336.PubMedGoogle Scholar
  128. Gerardin, P., Cohen D., Mazet P., & Flament, M. F. (2002). Drug treatment of conduct disorder in young people. European Neuropsychopharmacology, 12, 361-370.PubMedGoogle Scholar
  129. Giedd, J. N., Blumenthal, J., Molloy, E., & Castellanos, F. X. (2001). Brain imaging of attention deficit/hyperactivity disorder. Annals of the New York Academy of Sciences, 931, 33-49.Google Scholar
  130. Gillberg, C., Melander, H., von Knorring, A., Janols, L. O., Thernlund, G., Hägglöf, B., et al. (1997). Long-term stimulant treatment of children with Attention-Deficit/Hyperactivity Disorder: A randomized double-blind placebo-controlled trial. Archives of General Psychiatry, 54, 857-864.PubMedGoogle Scholar
  131. Gillberg, C., Persson, E., Grufman, M., & Themner, U. (1986). Psychiatric disorders in mildly and severely mentally retarded urban children and adolescents: Epidemiological aspects. British Journal of Psychiatry, 149, 68-74.PubMedGoogle Scholar
  132. Gilligan, J., & Lee, B. (2004). The psychopharmacologic treatment of violent youth. Annals of the New York Academy of Sciences, 1036, 356-381.PubMedGoogle Scholar
  133. Gimpel, G. A., Collett, B. R., Veeder, M. A., Gifford, J. A., Sneddon, P., Bushman, B., et al. (2005). Effects of stimulant medication on cognitive performance of children with ADHD. Clinical Pediatrics, 44, 405-411.PubMedGoogle Scholar
  134. Gittleman, R., Klein, D. F., & Feingold, J. (1983). Children with reading disorders II: Effects of methylphenidate in combination with reading remediation. Journal of Children, Psychology, & Psychiatry, 24, 193-212.Google Scholar
  135. Goldberg, J. (2002). Clonidine and methylphenidate were effective for Attention Deficit Hyperactivity Disorder in children with comorbid tics. Evidence Based Mental Health, 5, 122.PubMedGoogle Scholar
  136. Golden, G. S. (1988). The relationship between stimulant medication and tics. Pediatric Annals, 17, 405-408.PubMedGoogle Scholar
  137. Grcevich, S., Rowane, W. A., & Marcellino, B. (2001). Retrospective comparison of Adderall and methylphenidate in the treatment of Attention Deficit Hyperactivity Disorder. Journal of Child & Adolescent Psychopharmacology, 11, 35-41.Google Scholar
  138. Greenhill, L. L. (2002). Efficacy and safety of OROS MPH in adolescents with ADHD. Presented at 49th Annual Meeting of the American Academy of Child & Adolescent Psychiatry, San Francisco, CA, October 22-27.Google Scholar
  139. Greenhill, L. L., Abikoff, H. B., Arnold, L. E., Cantwell, D. P., Conners, C. K., Elliott, G., et al. (1996). Medication treatment strategies in the MTA Study: Relevance to clinicians and researchers. Journal of the American Academy of Child & Adolescent Psychiatry, 35, 1304-1313.Google Scholar
  140. Greenhill, L. L., Pliska, S., Dulcan, M. K., Bernet, W., Arnold, V., Beitchman, J., et al. (2002). Practice parameter for use of stimulant medications in the treatment of children, adolescents, and adults. Journal of the American Academy of Child & Adolescent Psychiatry, 41, 26S-49S.Google Scholar
  141. Greenhill, L. L., Swanson, J. M., Vitiello, B., Davies, M., Clevenger, W., Wu, M., et al. (2001). Impairment and deportment responses to different methylphenidate doses in children with ADHD: the MTA Titration Trial. Journal of the American Academy of Child & Adolescent Psychiatry, 40, 180-187.Google Scholar
  142. Grimwood, K., Anderson, P., Anderson, V., Tan, L., & Nolan, T. (2000). Twelve-year outcomes following bacterial meningitis: Further evidence for persisting effects. Archives of Disease in Childhood, 83, 111-116.PubMedGoogle Scholar
  143. Gross-Tsur, V., Manor, O., van der Meere, J., Joseph, A., & Shalev, R. S. (1997). Epilepsy and Attention Deficit Hyperactivity Disorder: Is methylphenidate safe and effective? Journal of Pediatrics, 130, 670-674.PubMedGoogle Scholar
  144. Gureasko-Moore, D. P., DuPaul, G. J., & Power, T. J. (2005). Stimulant treatment for Attention-Deficit/Hyperactivity Disorder: Medication monitoring practices of school psychologists. School Psychology Review, 34, 232-245.Google Scholar
  145. Hechtman, L., Weiss, G., Perlman, T., & Amsel, R. (1984). Hyperactives as young adults: initial predictors of adult outcome. Journal of the American Academy of Child Psychiatry, 23, 250-260.Google Scholar
  146. Hamarman, S., Fossella, J., Ulger, C., Brimacombe, M., & Dermody, J. (2004). Dopamine receptor 4 (DRD4) 7-repeat allele predicts methylphenidate dose response in children with Attention Deficit Hyperactivity Disorder: A pharmacogenetic study. Journal of Child & Adolescent Psychopharmacology, 14, 564-574.Google Scholar
  147. Handen, B. L., Breaux, A. M., Gosling, A., Ploof, D. L., & Feldman, H. (1990). Efficacy of methylphenidate among mentally retarded children with Attention Deficit Hyperactivity Disorder. Pediatrics, 86, 922-930.PubMedGoogle Scholar
  148. Handen, B. L., Breaux, A. M., Janosky, J., McAuliffe, S., Feldman, H., & Gosling, A. (1992). Effects and noneffects of methylphenidate in children with mental retardation and ADHD. Journal of the American Academy of Child & Adolescent Psychiatry, 31, 455-461.Google Scholar
  149. Handen, B. L., Feldman, H., Gosling, A., Breaux, A. M., & McAuliffe, S. (1991). Adverse side effects of methylphenidate among mentally retarded children with ADHD. Journal of the American Academy of Child & Adolescent Psychiatry, 30, 241-245.Google Scholar
  150. Handen B. L., Feldman, H. M., Lurier A., & Murray, P. J. (1999). Efficacy of methylphenidate among preschool children with developmental disabilities and ADHD. Journal of the American Academy of Child & Adolescent Psychiatry, 38, 805-812.Google Scholar
  151. Hanisch, C., Konrad, K., Gunther, T., & Herpertz-Dahlmann, B. (2004). Age-dependent neuropsychological deficits and effects of methylphenidate in children with Attention-Deficit/Hyperactivity Disorder: A comparison of pre- and grade-school children. Journal of Neural Transmission, 111, 865-881.PubMedGoogle Scholar
  152. Hechtman, L., Abikoff, H., Klein, R. G., Weiss, G., Respitz, C., Kouri, J., et al. (2004). Academic achievement and emotional status of children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. Journal of the American Academy of Child Adolescence & Psychiatry, 43, 812-819.Google Scholar
  153. Hechtman, L., & Greenfield, B. (2003). Adult Attention Deficit/Hyperactivity Disorder: Recognition and treatment. Contemporary Psychiatry, 1, 1-10.Google Scholar
  154. Hesslinger, B., Tebartz van Elst, L., Thiel, T., Haegele, K., Hennig, J., & Ebert, D. (2002). Frontoorbital volume reductions in adult patients with Attention Deficit Hyperactivity Disorder. Neuroscience Letters, 328, 319-321.PubMedGoogle Scholar
  155. Hinshaw, S. P. (1991). Stimulant medication and the treatment of aggression in children with attentional deficits. Journal of Clinical Child Psychology, 20, 301-312.Google Scholar
  156. Hinshaw, S. P., & Melnick, S. (1995). Peer relationships in children with Attention-Deficit Hyperactivity Disorder with and without comorbid aggression. Developmental Psychopathology, 7, 627-647.Google Scholar
  157. Hinshaw, S. P., Heller, T., & McHale, J. P. (1992). Covert antisocial behavior in boys with Attention-Deficit Hyperactivity Disorder: External validation and effects of methylphenidate. Journal of Consulting & Clinical Psychology, 60, 274-281.Google Scholar
  158. Hinshaw, S. P., Henker, B., & Whalen, C. K. (1984). Self-control in hyperactive boys in anger-inducing situations: Effects of cognitive-behavioral training and of methylphenidate. Journal of Abnormal Child Psychology, 12, 155-177.Google Scholar
  159. Hinshaw, S. P., Henker, B., Whalen, C. K., Erhardt, D., & Dunnington, R. E., Jr. (1989). Aggressive, prosocial, and nonsocial behavior in hyperactive boys: Dose effects of methylphenidate in naturalistic settings. Journal of Consulting & Clinical Psychology, 57, 636-643.Google Scholar
  160. Hinshaw, S. P., Owens, E. B., Wells, K. C., Kraemer, H. C., Abikoff, H. B., Arnold L. E., et al. (2000). Family processes and treatment outcome in the MTA: Negative/ineffective parenting practices in relation to multimodal treatment. Journal of Abnormal Child Psychology, 28, 555-568.PubMedGoogle Scholar
  161. Hodgens, J. B., Cole, J., & Boldizar, J. (2000). Peer-based differences among children with ADHD. Journal of Clinical Child Psychology, 29, 443-452.PubMedGoogle Scholar
  162. Hood, J., Rankin, P., & Isaacs, E. (2005). Immediate effects of methylphenidate on cognitive attention skills of children with Attention Deficit Hyperactivity Disorder. Developmental Medicine & Child Neurology, 47, 408-414.Google Scholar
  163. Hornyak, J. E., Nelson, V. S., & Hurvitz, E. A. (1997). The use of methylphenidate in pediatric traumatic brain injury. Pediatric Rehabilitation, 1, 15-17.PubMedGoogle Scholar
  164. Hoza, B., Gerdes, A. C., Mrug, S., Hinshaw, S. P., Bukowski, W. M., Gold, J. A., et al. (2005). Peer-assessed outcomes in the Multimodal Treatment Study of Children with Attention Deficit Hyperactivity Disorder. Journal of Clinical Child & Adolescent Psychology, 34, 74-86.Google Scholar
  165. Huesmann, L. R., Lagerspetz, K., & Eron, L. D. (1984). Intervening variables in the TV violence-aggression relation: Evidence from two countries. Developmental Psychology, 20, 746-775.Google Scholar
  166. Hupp, S. D., Reitman, D., Northup, J., O’Callaghan, P. M., & LeBlanc, M. (2002). The effects of delayed rewards, tokens, and stimulant medication on sportsmanlike behavior with ADHD-diagnosed children. Behavior Modification, 26, 148-162.PubMedGoogle Scholar
  167. Huss, M., & Lehmkuhl, U. (2002). Methylphenidate and substance abuse: A review of pharmacology, animal and clinical studies. Journal of Attention Disorders, 6:(suppl. 1), S65-S71.Google Scholar
  168. Jacobvitz, D., Sroufe, A., Stewart, M., & Leffert, N. (1990). Treatment of attentional and hyperactivity problems in children with sympathomimetic drugs: A comprehensive review. Journal of the American Academy of Child & Adolescent Psychiatry, 29, 677-688.Google Scholar
  169. Jadad, A. R., Booker, L., Gauld, M., Kakuma, R., Boyle, M., Cunningham, C. E., et al. (1999). The treatment of Attention-Deficit Hyperactivity Disorder: An annotated bibliography and critical appraisal of published systematic reviews and meta-analyses. Canadian Journal of Psychiatry, 44, 1025-1035.Google Scholar
  170. James, R. S., Sharp, W. S., Bastain, T. M., Lee, P. P., Walter, J. M., Czarnowlewski, M., et al. (2001). Double-blind, placebo-controlled study of single-dose amphetamine formulations in ADHD. Journal of the American Academy of Child & Adolescent Psychiatry, 40, 1268-1276.Google Scholar
  171. Jensen, P. S. (2001). ADHD comorbidity and treatment outcomes in the MTA. Journal of the American Academy of Child & Adolescent Psychiatry, 40, 134-136.Google Scholar
  172. Jensen, P. S., Bhatara, V. S., Vitiello, B., Hoagwood, K., Feil, M., & Burke, L. B. (1999). Psychoactive medication prescribing practices for U.S. children: Gaps between research and clinical practice.Journal of the American Academy of Child & Adolescent Psychiatry, 38, 557-565.Google Scholar
  173. Jensen, P. S., Hinshaw, S. P., Swanson, J. M., Greenhill, L. L., Conners, C. K., Arnold, L. E., et al. (2001a). Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): Implications and applications for primary care providers. Journal of Developmental & Behavioral Pediatrics, 22, 60-73.Google Scholar
  174. Jensen, P. S., Hinshaw, S. P., Kraemer, H. C., Lenora, N., Newcorn, J. H., Abikoff, H. B., et al. (2001b). ADHD comorbidity findings from the MTA study: Comparing comorbid subgroups. Journal of the American Academy of Child & Adolescent Psychiatry, 40, 147-158.Google Scholar
  175. Johnson, C. R., Handen, B. L., Lubetsky, M. J., & Sacco, K. A. (1994). Efficacy of methylphenidate and behavioral intervention on classroom behavior in children with ADHD and mental retardation. Behavior Modification, 18, 470-487.PubMedGoogle Scholar
  176. Johnston, C., Pelham, W. E., Hoza, J., & Sturges, J. (1988). Psychostimulant rebound in Attention Deficit disordered boys. Journal of the American Academy of Child & Adolescent Psychiatry, 27, 806-810.Google Scholar
  177. Johnston, C., Seipp, C., Hommersen, P., Hoza, B., & Fine, S. (2005). Treatment choices and experiences in Attention Deficit and Hyperactivity Disorder: Relations to parents’ beliefs and attributions. Child Care & Health Development, 31, 669-677.Google Scholar
  178. Jonkman, L. M., Kemner, C., Verbaten, M. N., van Engeland, H., Kenemans, J. L., Camfferman, G., et al. (1999). Perceptual and response interference in children with Attention-Deficit Hyperactivity Disorder and the effects of methylphenidate. Psychophysiology, 36, 419-429.PubMedGoogle Scholar
  179. Joyce, P. R., Donald, R. A., Nicholls, M. G., Livesey, J. H., & Abbott, R. M. (1986). Endocrine and behavioral responses to methylphenidate in normal subjects. Biological Psychiatry, 21, 1015-1023.PubMedGoogle Scholar
  180. Kajs-Wyllie, M. (2002). Ritalin revisited: does it really help in neurological injury? Journal of Neuroscience Nursing, 34, 303-313.PubMedGoogle Scholar
  181. Kaminester, D. D. (1997). Attention Deficit Hyperactivity Disorder and methylphenidate: When society misunderstands medicine. McGill Journal of Medicine, 3, 105-114.Google Scholar
  182. Kaplan, S., Heiligenstein, J., West, S., Busner, J., Harder, D., Dittman, R., et al. (2004). Efficacy and safety of atomoxetine in childhood Attention-Deficit/Hyperactivity Disorder with comorbid oppositional defiant disorder. Journal of Attention Disorders, 8, 45-52.PubMedGoogle Scholar
  183. Kates, W. R., Frederikse, M., Mostofsky, S. H., Folley, B. S., Cooper, K., Mazur-Hopkins, P., et al. (2002). MRI parcellation of the frontal lobe in boys with Attention Deficit Hyperactivity Disorder or Tourette Syndrome. Psychiatry Research, 116, 63-81.PubMedGoogle Scholar
  184. Kempton, S., Vance, A., Maruff, P., Luk, E., Costin, J., & Pantelis, C. (1999). Executive function and Attention Deficit Hyperactivity Disorder: Stimulant medication and better executive function performance in children. Psychological Medicine, 29, 527-538.PubMedGoogle Scholar
  185. Kilpelainen, R., Luoma, L., Herrgard, E., Ypparila, H., Partanen, J., & Karhu, J. (1999). Persistent frontal P300 brain potential suggests abnormal processing of auditory information in distractible children. Neuroreport, 10, 3405-3410.PubMedGoogle Scholar
  186. Klassen, A., Miller, A., Raina, P., Lee, S. K., & Olsen, L. (1999). Attention-Deficit Hyperactivity Disorder in children and youth: A quantitative systematic review of the efficacy of different management strategies. Canadian Journal of Psychiatry, 44, 1007-1016.Google Scholar
  187. Klein, R. G., & Abikoff, H. (1997). Behavior therapy and methylphenidate in the treatment of children with ADHD. Journal of Attention Disorders, 2, 89-114.Google Scholar
  188. Klein, R. G., Abikoff, H., Klass, E., Ganeles, D., Seese, L. M., & Pollack, S. (1997). Clinical efficacy of methylphenidate in conduct disorder with and without Attention Deficit Hyperactivity Disorder. Archives of General Psychiatry, 54, 1073-1080.PubMedGoogle Scholar
  189. Klein-Schwartz, W. (2002). Abuse and toxicity of methylphenidate. Current Opinion in Pediatrics, 14, 219-223.PubMedGoogle Scholar
  190. Klorman, R. (1986). Attention Deficit Disorder in adolescence. In R. A. Feldman & A. R. Stiffman (Eds.), Advances in adolescent mental health (Vol. 1, pp. 19-62). Greenwhich, CT: JAI Press.Google Scholar
  191. Klorman, R., Brumaghim, J. T., Fitzpatrick, P. A., & Borgstedt, A. D. (1991). Methylphenidate speeds evaluation processes of Attention Deficit Disorder adolescents during a continuous performance test. Journal of Abnormal Child Psychology, 19, 263-283.PubMedGoogle Scholar
  192. Kollins, S. H. (2004). Methodological issues in the assessment of medication effects in children diagnosed with Attention Deficit Hyperactivity Disorder (ADHD). Journal of Behavioral Education, 13, 247-266.Google Scholar
  193. Kollins, S. H., Rush, C. R., Pazzaglia, P. J., & Ali, J. A. (1998). Comparison of acute behavioral effects of sustained-release and immediate-release methylphenidate. Experimental & Clinical Psychopharmacology, 6, 367-374.Google Scholar
  194. Konrad, K., Gunther, T., Hanisch, C., & Herpertz-Dahlmann, B. (2004). Differential effects of methylphenidate on attentional functions in children with Attention-Deficit/Hyperactivity Disorder. Journal of the American Academy of Child & Adolescent Psychiatry, 43, 191-198.Google Scholar
  195. Kurlan, R. (1997). Tourette syndrome: Treatment of tics. Neurologic Clinics, 15, 403-409.PubMedGoogle Scholar
  196. Kurlan, R. (2003). Tourette’s syndrome: Are stimulants safe?Current Neurology & Neuroscience Reports, 3, 285-288.Google Scholar
  197. Kutcher, S., Aman, M., Brooks, S. J., Buitelaar, J., van Daalen, E., Fegert, J., et al. (2004). International consensus statement on Attention-Deficit/Hyperactivity Disorder (ADHD) and disruptive behaviour disorders (DBDs): Clinical implications and treatment practice suggestions. European Journal of Neuropsychopharmacology, 14, 11-28.Google Scholar
  198. Law, S. F., & Schachar, R. J. (1999). Do typical clinical doses of methylphenidate cause tics in children treated for Attention-Deficit Hyperactivity Disorder? Journal of the American Academy of Child & Adolescent Psychiatry, 38, 944-951.Google Scholar
  199. Lawrence, C. A., Barry, R. J., Clarke, A. R., Johnstone, S. J., McCarthy, R., Selikowitz, M., et al. (2005). Methylphenidate effects in Attention Deficit/Hyperactivity Disorder: Electrodermal and ERP measures during a continuous performance task. Psychopharmacology (Berl), 183, 81-91.Google Scholar
  200. LeFever, G. B., Arcona, A. P., & Antonuccio, D. O. (2003). ADHD among American schoolchildren: Evidence of overdiagnosis and overuse of medication. Scientific Review of Mental Health Practice, 2, 105-122.Google Scholar
  201. Lerer, R. J., Artner, J., & Lerer, M. P. (1979). Handwriting deficits in children with minimal brain dysfunction: Effects of methylphenidate (Ritalin) and placebo. Journal of Learning Disabilities, 12, 450-455.Google Scholar
  202. Lerer, R. J., & Lerer, P. (1976). The effects of methylphenidate on the soft neurological signs of hyperactive children. Pediatrics, 57, 521-525.Google Scholar
  203. Loney, J., & Milich, R. (1982). Hyperactivity, inattention, and aggression in clinical practice. In M. Wolraich, & D. Routh (Eds.), Advances in development and behavioral pediatrics (Vol. 3, pp. 113-147). Greenwich, CT: JAI Press.Google Scholar
  204. Mahalick, D. M., Carmel, P. W., Greenberg, J. P., Molofsky, W., Brown, J. A., Heary, R. F., et al. (1998). Psychopharmacologic treatment of acquired attention disorders in children with brain injury. Pediatric Neurosurgery, 29, 21-26.Google Scholar
  205. Mann, C. A., Lubar, J. F., Zimmerman, A. W, Miller, C. A., & Muenchen, R. A. (1992). Quantitative analyses of EEG in boys with Attention Deficit Hyperactivity Disorder: A controlled study with clinical implications. Pediatric Neurology, 8, 3036.Google Scholar
  206. Mannuzza, S., Klein, R. G., & Moulton, J. L. (2003). Does stimulant treatment place children at risk for adult substance abuse? A controlled, prospective follow-up study. Journal of Child & Adolescent Psychopharmacology, 13, 273-282.Google Scholar
  207. March, J. S. Swanson, J. M., Arnold, L. E., Hoza, B., Conners, C. K., Hinshaw, S. P., et al. (2000). Anxiety as a predictor and outcome variable in the multimodal treatment study of children with ADHD (MTA). Journal of Abnormal Child Psychology, 28, 527-541.PubMedGoogle Scholar
  208. Matier, K., Halperin, J. M., Sharma, V., Newcorn, J. H., & Sathaye, N. (1992). Methylphenidate response in aggressive and nonaggressive ADHD children: Distinctions on laboratory measures of symptoms. Journal of the American Academy of Child & Adolescent Psychiatry, 31, 219-225.Google Scholar
  209. McCormick, L. H. (2003). ADHD treatment and academic performance: A case series. Journal of Family Practice, 52, 620-626.PubMedGoogle Scholar
  210. McGough, J. J. (2005). Attention-Deficit/Hyperactivity Disorder pharmacogenomics. Biological Psychiatry, 57, 1367-1373.PubMedGoogle Scholar
  211. McMaster University Evidence-Based Practice Center. (1999). Treatment of Attention-Deficit Hyperactivity Disorder. Evidence Report/Technology Assessment no. 11, AHCPR Publication No. 99-E018. Rockville, MD: Agency for Health Care Policy & Research.Google Scholar
  212. McNeal R. E., Roberts, M. C., & Barone V. J. (2000). Mothers’ and children’s perceptions of medication for children with Attention-Deficit Hyperactivity Disorder. Child Psychiatry & Human Development, 30, 173-187.Google Scholar
  213. Mehta, M. A., Goodyer, I. M., & Sahakian, B. J. (2004). Methylphenidate improves working memory and set-shifting in AD/HD: Relationships to baseline memory capacity. Journal of Child Psychology & Psychiatry & Allied Disciplines, 45, 293-305.Google Scholar
  214. Milberger, S., Biederman, J., Faraone, S. V., Chen, L., & Jones, J. (1997). ADHD is associated with early initiation of cigarette smoking in children and adolescents. Journal of Academic Child Adolescent Psychiatry, 36, 37-44.Google Scholar
  215. Milch, R., & Landau, S. (1982). Socialization and peer relations hyperactive children. In K. D. Gadow, & I. Bialer (Eds.),Advances in learning and behavioral disabilities: A recent annual (Vol. 1, pp. 283-339). Greenwich, CT: JAI Press.Google Scholar
  216. Miller, L. S., Koplewicz, H. S., & Klein, R. G. (1997). Teacher ratings of hyperactivity, inattention, and conduct problems in preschoolers. Journal of Abnormal Child Psychology, 25, 113-119.PubMedGoogle Scholar
  217. Modi, N. B., Lindemulder, B., & Gupta, S. K. (2000). Single- and multiple-dose pharmacokinetics of an oral once-a-day osmotic controlled-release OROS (methylphenidate HCl) formulation. Journal of Clinical Pharmacology, 40, 379-388.PubMedGoogle Scholar
  218. Moleski, M. (2000). Neuropsychological, neuroanatomical, and neurophysiological consequences of CNS chemotherapy for acute lymphoblastic leukemia. Archives of Clinical Neuropsychology, 15, 603-630.PubMedGoogle Scholar
  219. Moline, S., & Frankenberger, W. (2001). Use of stimulant medication for treatment of Attention-Deficit/Hyperactivity Disorder: A survey of middle and high school students’ attitudes. Psychology in the Schools, 38, 569-584.Google Scholar
  220. Morris, R. D., Krawiecki, N. S., Kullgren, K. A., Ingram, S. M., & Kurcynski, B. (2000). Brain tumors. In K. O. Yeates, M. D. Ris, & H. G. Taylor (Eds.), Pediatric Neuropsychology (pp. 74-91). New York: Guilford Press.Google Scholar
  221. Moser, S. E., & Bober, J. F. (2002). Behavioral problems in children and adolescents. In R. E. Rakel (Ed.), Textbook of family practice (6th ed.) (pp. 641-644). Philadelphia: W. B. Saunders.Google Scholar
  222. Mostofsky, S. H., Cooper, K. L., Kates, W. R., Denckla, M. B., & Kaufmann, W. E. (2002). Smaller prefrontal and premotor volumes in boys with Attention-Deficit/Hyperactivity Disorder, Biological Psychiatry, 52, 785-794.PubMedGoogle Scholar
  223. MTA Cooperative Group. (1999a). A 14-month randomized clinical trial of treatment strategies for Attention-Deficit Hyperactivity Disorder (ADHD). Archives of General Psychiatry, 56, 1073-1086.Google Scholar
  224. MTA Cooperative Group. (1999b). Moderators and mediators of treatment response for children with Attention-Deficit/Hyperactivity Disorder: The multimodal treatment study of children with Attention-Deficit/Hyperactivity Disorder. Archives of General Psychiatry, 56, 1088-1096.Google Scholar
  225. MTA Cooperative Group. (2004a). National Institute of Mental Health Multimodal Treatment Study of ADHD: 24-Month outcomes of treatment strategies for ADHD. Pediatrics, 113, 754-760.Google Scholar
  226. MTA Cooperative Group. (2004b). National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: Changes in effectiveness and growth after the end of treatment. Pediatrics, 113, 762-769.Google Scholar
  227. Mulas, F., Capilla, A., Fernandez, S., Etchepareborda, M. C., Campo, P., Maestu, F., et al. (2006). Shifting-related brain magnetic activity in Attention-Deficit/Hyperactivity Disorder. Biological Psychiatry, 59, 373-379.Google Scholar
  228. Mulhern, R. K., White, H. A., Glass, J. O., Kun, L. E., Leigh, L., Thompson, S. J., et al. (2004). Attentional functioning and white matter integrity among survivors of malignant brain tumors of childhood. Journal of the International Neuropsychological Society, 10, 180-189.PubMedGoogle Scholar
  229. Musten, L. M., Firestone, P., Pisterman, S., Bennett, S., & Mercer, J. (1997). Effects of methylphenidate on preschool children with ADHD: Cognitive and behavioral functions. Journal of the American Academy of Child & Adolescent Psychiatry, 36, 1407-1415.Google Scholar
  230. Nangle, D. W., & Erdley, C. A. (Eds.). (2001). New directions for child and adolescent development: The role of friendship in psychological adjustment. San Francisco: Jossey-Bass.Google Scholar
  231. Newcorn, J. H., Halperin, J. M., Jensen, P. S., Abikoff, H. B., Arnold, E., Cantwell, D. P., et al. (2001). Symptom profiles in children with ADHD: Effects on comorbidity and gender. Journal of the American Academy of Child & Adolescent Psychiatry, 40, 137-146.Google Scholar
  232. Oades, R. D., Dittman-Balcar, A., Schepker, R., Eggers, C., & Zerbin, D. (1996). Auditory event-related potentials (erps) and mismatch negativity (mmn) in healthy children and those with Attention-Deficit or Tourette/tic symptoms. Biological Psychology, 12, 163-185.Google Scholar
  233. O’Driscoll, G. A., Depatie, L., Holahan, A. V., Savion-Lemieux, T., Barr, R. G., Jolicoeur, C., et al. (2005). Executive functions and methylphenidate response in subtypes of Attention-Deficit/Hyperactivity Disorder. Biological Psychiatry, 57, 1452-1460.PubMedGoogle Scholar
  234. Overmeyer, S., Bullmore, E. T., Suckling, J., Simmons, A., Williams, S. C., Santosh, P. J., et al. (2001). Distributed grey and white matter deficits in Hyperkinetic Disorder: MRI evidence for anatomical abnormality in an attentional network. Psychological Medicine, 31, 1425-1435.PubMedGoogle Scholar
  235. Palumbo, D., Spencer, T., Lynch, J., Co-Chien, H., & Faraone, S. V. (2004). Emergence of tics in children with ADHD: Impact of once-daily OROS methylphenidate therapy. Journal of Child & Adolescent Psychopharmacology, 14, 185-194.Google Scholar
  236. Patrick, K. S., Muellar, R. A., Gualtieri, C. T., & Breese, G. R. (1987). Pharmacokinetics and actions of methylphenidate. In H. Y. Meltzer (Ed.), Psychopharmacology: the third generation of progress (pp. 1387-1395). New York: Raven.Google Scholar
  237. Pearson, D. A., Santos, C. W., Casat, C. D., Jerger, S. W., Loveland, K. A., Faria, L. P., et al. (2004). Treatment effects of methylphenidate on cognitive functioning in children with mental retardation and ADHD. Journal of the American Academy of Child & Adolescent Psychiatry, 43, 677-685.Google Scholar
  238. Pearson, D. A., Santos, C. W., Roache, J. D., Casat, C. D., Loveland, K. A., Lachar, D., et al. (2003). Treatment effects of methylphenidate on behavioral adjustment in children with mental retardation and ADHD. Journal of the American Academy of Child & Adolescent Psychiatry, 42, 209-216.Google Scholar
  239. Peeples, E. E., Searls, D. T., & Wellingham, J. P. (1995). Attention-Deficit Hyperactivity Disorder: A longitudinal case study of handwriting characteristics.Perceptual & Motor Skills, 81, 1243-1252.Google Scholar
  240. Pelham, W. E., Jr. (2000). Implications of the MTA study for behavioral and combined treatments. The ADHD Report, 8, 9-16.Google Scholar
  241. Pelham, W. E., Aronoff, H. R., Midlam, J. K., Shapiro, C. J., Gnagy, E. M., Chronis, A. M., et al. (1999). A comparison of Ritalin and Adderall: Efficacy and time-course in children with Attention-Deficit/Hyperactivity Disorder. Pediatrics, 103, 43.Google Scholar
  242. Pelham, W. E., Bender, M. E., Caddell, J., Booth, S., & Moorer, S. H. (1985). Methylphenidate and children with Attention Deficit Disorder: Dose effects on classroom academic and social behavior. Archives of General Psychiatry, 42, 948-952.PubMedGoogle Scholar
  243. Pelham, W. E. Jr., Carlson, C., Sams, S. E., Vallano, G., Dixon, M. J., & Hoza, B. (1993). Separate and combined effects of methylphenidate and behavior modification on boys with Attention Deficit-Hyperactivity Disorder in the classroom. Journal of Consulting & Clinical Psychology, 61, 506-515.Google Scholar
  244. Pelham, W. E., Fabiano, G. A., & Massetti, G. M. (2005). Evidence-based assessment of Attention Deficit Hyperactivity Disorder in children and adolescents. Journal of Clinical Child & Adolescent Psychology, 34, 449-476.Google Scholar
  245. Pelham, W. E., Gnagy, E. M., Burrows-Maclean, L., Williams, A., Fabiano, G. A., Morrisey, S. M., et al. (2001). Once-a-day Concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settings. Pediatrics, 107, 105.Google Scholar
  246. Pelham, W. E., Greenslade, K. E., Vodde-Hamilton, M. A., Murphy, D. A., Greenstein, J. J., Gnagy, E. M., et al. (1990). Relative efficacy of long-acting CNS stimulants on children with Attention Deficit-Hyperactivity Disorder: A comparison of standard methylphenidate, sustained-release methylphenidate, sustained-release dextroamphetamine, and pemoline. Pediatrics, 86, 226-237.PubMedGoogle Scholar
  247. Pelham, W. E., & Hoza, J. (1987). Behavioral assessment of psychostimulant effects on ADHD children in a summer day treatment program. In R. Prinz (Ed.), Advances in behavioral assessment of children and families (Vol. 3, pp. 3-33). Greenwich, CT: JAI Press.Google Scholar
  248. Pelham, W. E., & Murphy, H. A. (1986). Attention deficit and conduct disorders. In M. Hersen (Ed.), Pharmacological and behavioral treatment: An integrative approach (pp. 108-148). New York: Wiley.Google Scholar
  249. Pelham, W. E., Jr., Swanson, J. M., Furman, M. B., & Schwindt, H. (1995). Pemoline effects on children with ADHD: A time-response by dose-response analysis on classroom measures. Journal of the American Academy of Child & Adolescent Psychiatry, 34, 1504-1513.Google Scholar
  250. Peloquin, L., & Klorman, R. (1986). Effects of methylphenidate on normal children’s moods, event-related potentials, and performance in memory, scanning and vigilance. Journal of Abnormal Psychology, 95, 88-98.PubMedGoogle Scholar
  251. Phelps, L., Brown, R. T., & Power, T. J. (2002). Pediatric psychopharmacology: Combining medical and psychosocial interventions. Washington, DC: American Psychological Association.Google Scholar
  252. Pfiffner, L. J., Calzada, E., & McBurnett, K. (2000). Interventions to enhance social competence. Child & Adolescent Psychiatric Clinics of North America, 9, 689-709.Google Scholar
  253. Pliszka, S. R. (2000). Patterns of comorbidity with Attention-Deficit/Hyperactivity Disorder. Child & Adolescent Psychiatric Clinics of North America, 9, 525-540.Google Scholar
  254. Pliszka, S. R., Browne, R. G., Olvera, R. L., & Wynne, S. K. (2000). A double-blind, placebo-controlled study of Adderall and methylphenidate in the treatment of Attention Deficit/Hyperactivity Disorder. Journal of the American Academy of Child & Adolescent Psychiatry, 39, 619-626.Google Scholar
  255. Pliszka, S. R., Greenhill, L. L., Crimson, M. L., Sedillo, A., Carlson, C., Conners, K. C., et al. (2000). The Texas children’s medication algorithm project: Report of the Texas consensus conference panel on medication treatment of childhood Attention-Deficit/Hyperactivity Disorder. Part I. Journal of the American Academy of Child & Adolescent Psychiatry, 39, 908-919.Google Scholar
  256. Poulton, A. (2005). Growth on stimulant medication; clarifying the confusion: A review. Archive of Disease in Childhood, 90, 801-806.Google Scholar
  257. Rappley, M. D., Mullan, P. B., Alvarez, F. J., Eneli, I. U., Wang, J., & Gardiner, J. C. (1999). Diagnosis of attention-deficit/hyperactivity disorder and use of psychotropic medication in very young children. Archives of Pediatric and Adolescent Medicine, 153, 1039-1045Google Scholar
  258. Rapport, M. D., Denney, C., DuPaul, G. J., & Gardner, M. J. (1994). Attention Deficit Disorder and methylphenidate: Normalization rates, clinical effectiveness, and response prediction in 76 children. Journal of the American Academy of Child & Adolescent Psychiatry, 33, 882-893.Google Scholar
  259. Rapport, M. D., DuPaul, G. J., & Kelly, K. L. (1989). Attention Deficit Hyperactivity Disorder and methylphenidate: The relationship between gross body weight and drug response in children. Psychopharmacology Bulletin, 25, 285-290.PubMedGoogle Scholar
  260. Rapport, M. D., & Kelly, K. L. (1991). Psychostimulant effects on learning and cognitive function: Findings and implications for children with Attention Deficit Hyperactivity Disorder. Clinical Psychology Review, 11, 61-92.Google Scholar
  261. Reitman, D., Hupp, S. D. A., O’Callaghan, P. M., Gulley, V., & Northup, J. (2001). The influence of a token economy and methylphenidate on attentive and disruptive behavior during sports with ADHD-diagnosed children. Behavior Modification, 25, 305-323.PubMedGoogle Scholar
  262. Richters, J. E., Eugene, A. L., Jensen, P. S., Abikoff, H., Conners, K. C., Greenhill, L. L., et al. (1995). NIMH collaborative multisite multimodal treatment study of children with ADHD: I. Background and rationale. Journal of the American Academy of Child & Adolescent Psychiatry, 34, 987-1000.Google Scholar
  263. Riordan, H. J., Flashman, L. A., Saykin, A. J., Frutiger, S. A., Carroll, K. E., & Huey, L. (1999). Neuropsychological correlates of methylphenidate treatment in adult ADHD with and without depression. Archives of Clinical Neuropsychology, 14, 217-233.PubMedGoogle Scholar
  264. Robison, L. M., Sclar, D. A., Skaer, T. L., & Galin, R. S. (1999). National trends in the prevalence of attention-deficit/hyperactivity disorder and the prescribing of methylphenidate among school age children: 1990-1995. Clinical Pediatrics (Phila), 38, 209-217.Google Scholar
  265. Roman, T., Schmitz, M., Polanczyk, G. V., Eizirik, M., Rohde, L. A., & Hutz, M. H. (2002). Further evidence for the association between Attention-Deficit/Hyperactivity Disorder and the dopamine-beta-hydroxylase gene. American Journal of Medical Genetics, 114, 154-158.PubMedGoogle Scholar
  266. Rubia, K., Noorlos, J., Smith, A., Gunning, B., & Sergeant, J. (2003). Motor timing deficits in community and clinical boys with hyperactive behavior: The effect of methylphenidate on motor timing. Journal of Abnormal Child Psychology, 31, 301-313.PubMedGoogle Scholar
  267. Rugino, T. A., & Samsock, T. C. (2003). Modafinil in children with Attention-Deficit Hyperactivity Disorder. Pediatric Neurology, 29, 136-142.PubMedGoogle Scholar
  268. Runnheim, V. A., Frankenberger, W. R., & Hazelkorn, M. N. (1996). Medicating students with emotional and behavioral disorders and ADHD: A state survey. Behavioral Disorder, 21, 306-314.Google Scholar
  269. Rutter, M. (1983). School effects on pupil progress: Research findings and policy implications. Child Development, 54, 1-29.Google Scholar
  270. Safer, D. J., & Krager, J. M. (1988). A survey of medication treatment for hyperactive/inattentive students. Journal of the American Medical Association, 260, 2256-2258.PubMedGoogle Scholar
  271. Safer, D. J., Zito, J. M., & Fine, E. M. (1996). Increased methylphenidate usage for Attention Deficit Disorder in the 1990s. Pediatrics, 98, 1084-1088.PubMedGoogle Scholar
  272. Samuels, J. A., Franco, K., Wan, F., & Sorof, J. M. (2005). Effect of stimulants on 24-h ambulatory blood pressure in children with ADHD: A double-blind, randomized, cross-over trial. Pediatric Nephrology, 21, 92-95.PubMedGoogle Scholar
  273. Sane, N., & McGough, J. J. (2002). MethyPatch Noven. Current Opinion in Investigational Drugs, 3, 1222-1224.PubMedGoogle Scholar
  274. Santosh, P. J., & Taylor, E. (2000). Stimulant drugs. European Journal of Child & Adolescent Psychiatry, 9, 27-43.Google Scholar
  275. Satel, S. L., & Nelson, J. C. (1989). Stimulants in the treatment of depression: A critical overview. Journal of Clinical Psychiatry, 50, 241-249.PubMedGoogle Scholar
  276. Satterfield, J. H. (1990). BEAM studies in ADD boys. In K. Conners, & M. Kinsbourne (Eds.), Attention Deficit Hyperactivity Disorder (pp. 127-136). Munich: Medizine Verlag Munchen.Google Scholar
  277. Satterfield, J. H., & Cantwell, D. P. (1974). Proceedings: CNS function and response to methylphenidate in hyperactive children. Psychopharmacology Bulletin, 10, 36-77.PubMedGoogle Scholar
  278. Satterfield, J. H., Schell, A. M., & Nicholas, T. (1994). Preferential neural processing of attended stimuli in Attention-Deficit Hyperactivity Disorder and normal boys. Psychophysiology, 31, 1-10.PubMedGoogle Scholar
  279. Schachar, R., Jadad, A. R., Gauld, M., Boyle, M., Booker, L., Snider, A., et al. (2002). Attention-Deficit Hyperactivity Disorder: Critical appraisal of extended treatment studies. Canadian Journal of Psychiatry, 47, 337-348.Google Scholar
  280. Schachter, H. M., Pham, B., King, J., Langford, S., & Moher, D. (2001). How efficacious and safe is short-acting methylphenidate for the treatment of Attention-Deficit Disorder in children and adolescents? A meta-analysis. Canadian Medical Association Journal, 165, 1475-1488.PubMedGoogle Scholar
  281. Scheres, A., Oosterlaan, J., Swanson, J., Morein-Zamir, S., Meiran, N., Schut, H., et al. (2003). The effect of methylphenidate on three forms of response inhibition in boys with AD/HD. Journal of Abnormal Child Psychology, 31, 105-120.PubMedGoogle Scholar
  282. Schachar, R. J., Tannock, R., Cunningham, C., & Corkum, P. V. (1997). Behavioral, situational and temporal effects of treatment of ADHD with methylphenidate. Journal of the American Academy of Child & Adolescent Psychiatry, 36, 754-763.Google Scholar
  283. Seifert, J., Scheuerpflug, P., Zillessen, K. E., Fallgater, A., & Warnke, A. (2003). Electrophysiological investigation of the effectiveness of methylphenidate in children with and without ADHD. Journal of Neural Transmission, 110, 821-829.PubMedGoogle Scholar
  284. Selikowitz, M. (2004). ADHD: The facts. Oxford: Oxford University Press.Google Scholar
  285. Sergeant, J. A., Oosterlaan, J., & Van der Meere, J. (1999). Information processing and energetic factors in Attention-Deficit/Hyperactivity Disorder. In H. C. Quay, & A. E. Hogan (Eds.), Handbook of disruptive behavior disorders (pp. 75-104). New York: Kluwer Academic/Plenum.Google Scholar
  286. Shafritz, K. M., Marchione, K. E., Gore, J. C., Shaywitz, S. E., & Shaywitz, B. A. (2004). The effects of methylphenidate on neural systems of attention in Attention Deficit Hyperactivity Disorder. American Journal of Psychiatry, 161, 1990-1997.PubMedGoogle Scholar
  287. Sharp, W. S., Walter, J. M. Marsh, W. L., Ritchie, G., Hamburger, S. D., Castellanos, F. (1999). ADHD in girls: Clinical comparability of a research sample. Journal of the American Academy of Child & Adolescent Psychiatry, 38, 40-47.Google Scholar
  288. Shaw, K., Mitchell, G., & Hilton, D. (2000). Are stimulants addictive in children? What the evidence says. Australian Family Physician, 29, 1202-1204.PubMedGoogle Scholar
  289. Sheppard, D. M., Bradshaw, J. L., Georgiou, N., Bradshaw, J. A., & Lee, P. (2000). Movement sequencing in children with Tourette’s Syndrome and Attention Deficit Hyperactivity Disorder. Movement Disorders, 15, 1184-1193.PubMedGoogle Scholar
  290. Short, E. J., Manos, M. J., Findling, R. L., & Schubel, E. A. (2004). A prospective study of stimulant response in preschool children: Insight from ROC analyses. Journal of the American Academy of Child & Adolescent Psychiatry, 43, 251-259.Google Scholar
  291. Siddall, M. (2005). Use of methylphenidate in traumatic brain injury. Annals of Pharmacotherapy, 39, 1309-1313.PubMedGoogle Scholar
  292. Smith, B., Pelham, W., Evans, S., Gnagy, E., Molina, B., Bukstein, O., et al. (1998). Dosage effects of methylphenidate on the social behavior of adolescents diagnosed with Attention-Deficit Hyperactivity Disorder. Experimental & Clinical Psychopharmacology, 6, 187-204.Google Scholar
  293. Smith, B. H., Waschbusch, D. A., Willoughby, M. T., & Evans, S. (2000). The efficacy, safety, and practicality of treatments for adolescents with Attention Deficit/Hyperactivity Disorder (ADHD). Clinical Child & Family Psychology Review, 3, 243-267.Google Scholar
  294. Snider, T. E., Busch, T., & Arrowood, L. (2003). Teacher knowledge of stimulant medication and ADHD. Remedial & Special Education, 24, 46-56.Google Scholar
  295. Soetens, E., Casaer, S., D’Hooge, R., & Hueting, J. E. (1995). Effect of amphetamine on long-term retention of verbal material. Psychopharmacology, 119, 155-162.PubMedGoogle Scholar
  296. Solanto, M. V. (1998). Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration. Behavior and Brain Research, 94, 127-152.Google Scholar
  297. Solanto, M. V., Arnsten, A. F. T., & Castellanos, F. X. (2001). Stimulant drugs and ADHD: Basic and clinical neuroscience. New York: Oxford University Press.Google Scholar
  298. Sonuga-Barke, E. J. S., Swanson, J. S., Coghill, D., DeCory, H. H., & Hatch, S. J. (2004). Efficacy of two once-daily methylphenidate formulations compared across dose levels at different times of the day: Preliminary indications from a secondary analysis of the COMACS study data. BMC Psychiatry, 4, 28.PubMedGoogle Scholar
  299. Sowell, E. R., Thompson, P. M., Welcome, S. E., Henkenius, A. L., Toga, A. W., & Peterson, B. S. (2003). Cortical abnormalities in children and adolescents with Attention-Deficit Hyperactivity Disorder. Lancet, 362, 1699-1707.PubMedGoogle Scholar
  300. Spencer, T. J., Biederman, J., Wilens, T., Harding, M., O’Donnell, D., & Griffin, S. (1996). Pharmacotherapy of ADHD across the lifecycle: A literature review. Journal of the American Academy of Child & Adolescent Psychiatry, 35, 409-432.Google Scholar
  301. Sprague, R. L., & Sleator, E. K. (1977). Methylphenidate in hyperkinetic children: Differences in dose effects on learning and social behavior. Science, 198, 1274-1276.PubMedGoogle Scholar
  302. Stein, M. A., & Greenhill, L. L. (2002). Once-daily Concerta (MPH) for adolescents and adults with ADHD. International Journal of Neuropsychopharmacology, 5, S162.Google Scholar
  303. Stein, M. A., Sarampote, C. S., Waldman, I. D., Robb, A. S., Conlon, C., Pearl, P., et al. (2003). A dose-response study of OROS methylphenidate in children with Attention-Deficit/Hyperactivity Disorder. Pediatrics, 112, e404-e413.PubMedGoogle Scholar
  304. Stein, M. A., Waldman, I. D., Sarampote, C. S., Seymour, K. E., Robb, A. S., Conlon, C., et al. (2005). Dopamine transporter genotype and methylphenidate dose response in children with ADHD. Neuropsychopharmacology, 30, 1374-1382.PubMedGoogle Scholar
  305. Steinhoff, K. (2004). Attention-Deficit/Hyperactivity Disorder: Medication treatment-dosing and duration of action. American Journal of Managed Care, 10, 99-106.Google Scholar
  306. Stowe, C. D., Gardner, S. F., Gist, C. C., Schulz, E. G., & Wells, T. G. (2002). 24-hour ambulatory blood pressure monitoring in male children receiving stimulant therapy.Annals of Pharmacotherapy, 36, 1142-1149.PubMedGoogle Scholar
  307. Sverd, J., Gadow, K. D., Nolan, E. E., Sprafkin, J., & Ezor, S. N. (1992). Methylphenidate in hyperactive boys with comorbid tic disorder. Advances in Neurology, 58, 271-281.PubMedGoogle Scholar
  308. Swanson, J. M. (1992). School-based assessments and interventions for ADD students. Irvine, CA: K.C. Publishing.Google Scholar
  309. Swanson, J. M. (1993). Effect of stimulant medication on hyperactive children: A review of reviews. Exceptional Child, 60, 154-162.Google Scholar
  310. Swanson, J. M., Cantwell, D., Lerner, M., McBurnett, K., & Hana, G. (1991). Effects of stimulant medication on learning in children with ADHD. Journal of Learning Disabilities, 24, 219-231.PubMedGoogle Scholar
  311. Swanson, J. M., Gupta, S., Lam, A., Shoulson, I., Lerner, M., Modi, N., et al. (2003). Development of a new once-a-day formulation of methylphenidate for the treatment of Attention-Deficit/Hyperactivity Disorder: Proof-of-concept and proof-of-product studies. Archives of General Psychiatry, 60, 204-211.PubMedGoogle Scholar
  312. Swanson, J. M., Gupta, S., Williams, L., Agler, D., Lerner, M., & Wigal, S. (2002). Efficacy of a new pattern of delivery of methylphenidate in the treatment of ADHD: Effects on activity level in the classroom and on the playground. Journal of the American Academy of Child & Adolescent Psychiatry, 41, 1306-1314.Google Scholar
  313. Swanson, J. M., Kraemer, H. C., Hinshaw, S. P., Arnold, L. E., Conners, C. K., Abikoff, H. B., et al. (2001). Clinical relevance of the primary findings of the MTA: Success rates based on severity of ADHD and ODD symptoms at the end of treatment. Journal of the American Academy of Child & Adolescent Psychiatry, 40, 168-179.Google Scholar
  314. Swanson, J., Lerner, M., & Williams, L. (1995). More frequent diagnosis of attention deficit-hyperactivity disorder. New England Journal of Medicine, 333, 944-944.Google Scholar
  315. Szymanski, L., & King, B. H. (1999). Practice parameters for the assessment and treatment of children, adolescents, and adults with mental retardation and comorbid disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 38, 5-31.Google Scholar
  316. Tannock, R., Ickowicz, A., & Schachar, R. (1995a). Differential effects of MPH on working memory in ADHD children with and without comorbid anxiety. Journal of the American Academy of Child & Adolescent Psychiatry, 34, 886-896.Google Scholar
  317. Tannock, R., Schachar, R., & Logan, G. (1995b). Methylphenidate and cognitive flexibility: Dissociated dose effects in hyperactive children. Journal of Abnormal Child Psychology, 23, 235-266.Google Scholar
  318. Tannock, R., Schachar, R. J., Can, R. P., Chajczyk, D., & Logan, G. (1989). Effects of methylphenidate on inhibitory control in hyperactive children. Journal of Abnormal Child Psychology, 17, 473-491.PubMedGoogle Scholar
  319. Teicher, M. H., Anderson, C. M., Polcari, A., Clod, C. A., Maas, L. C., & Renshaw, P. F. (2000). Functional deficits in basal ganglia of children with Attention-Deficit/Hyperactivity Disorder shown with functional magnetic resonance imaging relaxometry. Nature Medicine, 6, 470-473.PubMedGoogle Scholar
  320. Teicher, M. H., Polcari, A., Anderson, C. M., Andersen, S. L., Lowen, S. B., Navalta, C. P. (2003). Rate dependency revisited: Understanding the effects of methylphenidate in children with Attention Deficit Hyperactivity Disorder. Journal of Child & Adolescent Psychopharmacology, 13, 41-51.Google Scholar
  321. Teitelbaum, F., Martinez, R., Parker, A., Henderson, R., Roe, C., Kolling, B., et al. (2001). 2000 drug trend report. Maryland Heights, MO: Express Scripts.Google Scholar
  322. Thompson, S. J., Leigh, L., Christensen, R., Xiong, X., Kun, L. E., Heideman, R., et al. (2001). Immediate neurocognitive effects of methylphenidate on learning-impaired survivors of childhood cancer. Journal of Clinical Oncology, 19, 1802-1808.PubMedGoogle Scholar
  323. Tirosh, E., Sadeh, A., Munvez, R., & LaVie, P. (1993). Effects of methylphenidate on sleep in children with Attention-Deficit Hyperactivity Disorder: An activity monitor study. American Journal of Diseases of Children, 147, 1313-1315.PubMedGoogle Scholar
  324. Torres, C., Korones, D., Palumbo, D., Wissler, K., Vadasz, E., & Cox, C. (1996). Effect of methylphenidate in the postradiation attention and memory deficits in children. Annals of Neurology, 40, 331-332.Google Scholar
  325. Tourette’s Syndrome Study Group. (2002). Treatment of ADHD in children with tics: A randomized controlled trial.Neurology, 58, 527-536.Google Scholar
  326. Turgay, A. (2004). Aggression and disruptive behavior disorders in children and adolescents. Expert Review of Neurotherapeutics, 4, 623-632.PubMedGoogle Scholar
  327. Vaidya, C. J., Austin, G., & Kirkorian, G. (1998). Selective effects of methylphenidate in Attention Deficit Hyperactivity Disorder: A functional magnetic resonance study. Proceeds of the National Academy of Science, 95, 14494-14499.Google Scholar
  328. Van der Meere, J., Gunning, B., & Stemerdink, N. (1999). The effect of methylphenidate and clonidine on response inhibition and state regulation in children with ADHD.Journal of Child Psychology & Psychiatry, 40, 291-298.Google Scholar
  329. Vitiello, B., & Jensen, P. (1997). Medication development and testing in children and adolescents. Archives of General Psychiatry, 54, 871-876.PubMedGoogle Scholar
  330. Vitiello, B., Severe, J. B., Greenhill, L. L., Arnold, L. E., Abikoff, H. B., Bukstein, O. G., et al. (2001). Methylphenidate dosage for children with ADHD over time under controlled conditions: Lessons from the MTA. Journal of the American Academy of Child & Adolescent Psychiatry, 40, 188-196.Google Scholar
  331. Volkow, N. D., Fowler, J. S., Gatley, J. S., Logan, J., Wang, G. J., Ding, Y. S., et al. Dewey (1996). Evaluation of the human brain dopamine system with PET. Journal of Nuclear Medicine, 37, 1242-1256.PubMedGoogle Scholar
  332. Volkow, N. D., Fowler, J. S., Wang, G., Ding, Y., & Gatley, S. J. (2002). Mechanism of action of methylphenidate: insights from PET imaging studies. Journal of Attentional Disorders, 6, 31-43.Google Scholar
  333. Volkow, N. D., Wang, G. J., Fowler, J. S., & Ding, Y. S. (2005). Imaging the effects of methylphenidate on brain dopamine: New model on its therapeutic actions for Attention-Deficit/Hyperactivity Disorder. Biological Psychiatry, 57, 1410-1415.PubMedGoogle Scholar
  334. Waber, D. P., & Mullenix, P. J. (2000). Acute lymphoblastic leukemia. In K. O. Yeates, M. D. Ris, & H. G. Taylor (Eds.), Pediatric neuropsychology (pp. 300-319). New York: Guilford Press.Google Scholar
  335. Walling, V. R., & Pfefferbaum, B. (1990). The use of methylphenidate in a depressed adolescent with AIDS. Journal of Developmental & Behavioral Pediatrics, 11, 195-197.Google Scholar
  336. Weber, K. S., Frankenberger, W., & Heilman, K. (1992). The effects of Ritalin on the academic achievement of children diagnosed with Attention-Deficit Hyperactivity Disorder. Developmental Disabilities Bulletin, 20, 49-68.Google Scholar
  337. Weber, P., & Lutschg, J. (2002). Methylphenidate treatment. Pediatric Neurology, 26, 261-266.PubMedGoogle Scholar
  338. Weiss, M., & Murray, C. (2003). Assessment and management of Attention-Deficit Hyperactivity Disorder in adults. Canadian Medical Association Journal, 168, 715-722.PubMedGoogle Scholar
  339. Wells, K. C., Pelham, W. E., Kotkin, R. A., Hoza, B., Abikoff, H. B., Abramowitz, A., et al. (2000). Psychosocial treatment strategies in the MTA study: Rationale, methods, and critical issues in design and implementation. Journal of Abnormal Child Psychology, 28, 483-505.PubMedGoogle Scholar
  340. Wender, P. H. (1995). ADHD in Adults. New York: Oxford University Press.Google Scholar
  341. Wender, E. H. (2001). Managing stimulant medication for Attention-Deficit/Hyperactivity Disorder. Pediatricians in Review, 22, 183-189.Google Scholar
  342. Whalen, C. K., & Henker, B. (1991). Therapies for hyperactive children: Comparisons, combinations, and compromises. Journal of Consulting & Clinical Psychology, 59, 126-137.Google Scholar
  343. Whalen, C. K., Henker, B., Hinshaw, S. P., & Granger, D. A. (1989). Externalizing behavior disorders, situational generality, and the Type A Behavior Pattern. Child Development, 60, 1453-1462.PubMedGoogle Scholar
  344. Whalen, C., Henker, B., Swanson, J., Granger, D., Kliewer, W., Spencer, J., et al. (1987). Natural social behaviors in hyperactive children: Dose effects of methylphenidate. Journal of Consulting & Clinical Psychology, 55, 187-193.Google Scholar
  345. Wilens, T. E., & Biederman, J. (1992). The stimulants. Psychiatric Clinics of North America, 15, 191-222.PubMedGoogle Scholar
  346. Wilens, T. E., Faraone, S. V., Biederman, J., & Gunawardene, S. (2003). Does stimulant therapy of Attention-Deficit/Hyperactivity Disorder beget later substance abuse? A meta-analytic review of the literature. Pediatrics, 111, 179-185.PubMedGoogle Scholar
  347. Wilens, T. E., & Spencer, T. J. (2000). The stimulants revisited. Child & Adolescent Psychiatry Clinics of North America, 9, 573-603.Google Scholar
  348. Williams, J., Griebel, M. A., & Dykman, R. A. (1998). Neuropsychological patterns in pediatric epilepsy. Seizure, 7, 223-228.PubMedGoogle Scholar
  349. Williams, S. E., Douglas, R. M., Ayyangar, R., Schefft, B. K., & Berch, D. (1998). Recovery in pediatric brain injury: Is psychostimulant medication beneficial? Journal of Head Trauma Rehabilitation, 13, 73-81.PubMedGoogle Scholar
  350. Winsberg, B. G., & Comings, D. E. (1999). Association of the dopamine transporter gene (DAT1) with poor methylphenidate response. Journal of the American Academy of Child & Adolescent Psychiatry, 38, 1474-1477.Google Scholar
  351. Winsberg, B. G., Press, M., Bialer, I., & Kupietz, S. (1974). Dextroamphetamine and methylphenidate in the treatment of hyperactive/aggressive children. Pediatrics, 53, 236-241.PubMedGoogle Scholar
  352. Wolraich, M. L. (2003). The use of psychotropic medications in children: An American view. Journal of Child Psychology & Psychiatry & Allied Disciplines, 44, 159-168.Google Scholar
  353. Wolraich, M. L., & Doffing, M. A. (2004). Pharmacokinetic considerations in the treatment of Attention-Deficit Hyperactivity Disorder with methylphenidate. CNS Drugs, 18, 243-250.PubMedGoogle Scholar
  354. Wolraich, M. L., Greenhill, L. L., Pelham, W., Swanson, J., Wilens, T., Palumbo, D., et al. (2001). Randomized, controlled trial of OROS methylphenidate once a day in children with Attention-Deficit/Hyperactivity Disorder. Pediatrics, 108, 883-892.PubMedGoogle Scholar
  355. Wolraich, M. L., Lindgren, S., Stromquist, A., Milich, R., Davis, C., & Watson, D. (1990). Stimulant medication use by primary care physicians in the treatment of Attention Deficit Hyperactivity Disorder. Pediatrics, 86, 95-101.PubMedGoogle Scholar
  356. Zachor, D. A., Roberts, A. W., Hodgens, J. B., Isaacs, J. S., & Merrick, J. (2006). Effects of long-term psychostimulant medication on growth of children with ADHD. Research in Developmental Disabilities, 27, 162-174.Google Scholar
  357. Zillessen, K. E., Scheuerpflug, P., Fallgatter, A. J., Strik, W. K., & Warnke, A. (2001). Changes of the brain electrical fields during the continuous performance test in Attention-Deficit Hyperactivity Disorder-boys depending on methylphenidate medication. Clinical Neurophysiology, 112, 1166-1173.PubMedGoogle Scholar
  358. Zito, J. M., dosReis, S., Safer, D. J., & Riddle, M. A. (1998). Racial disparity in psychotropic medications prescribed for youths with Medicaid insurance in Maryland. Journal of the American Academy of Child & Adolescent Psychiatry, 37, 179-184.Google Scholar
  359. Zito, J. M., Safer, D. J., DosReis, S., Gardner, J. F., Boles, M., & Lynch, F. (2000). Trends in the prescribing of psychotropic medications to preschoolers. Journal of the American Medical Association, 283, 1025-1030.PubMedGoogle Scholar
  360. Zito, J. M., Safer, D. J., DosReis, S., Gardner, J. F., Magder, L., Soeken, K., et al. (2003). Psychotropic practice patterns for youth: A 10-year perspective. Archives of Pediatric Adolescent & Medicine, 157, 17-25.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • Ronald T. Brown
    • 1
  • Brian P. Daly
    • 1
  1. 1.College of Health ProfessionsProfessor of Public Health, Psychology, Pediatrics, Psychiatry and Behavioral Sciences, Temple University, Health Sciences CenterPhiladelphia

Personalised recommendations